Transurethral resection of prostate: the standard surgical intervention for benign prostatic hyperplasia

ABSTRACT

To report our experience, surgical results and complications of transurethral resection of prostate for benign prostatic hyperplasia. This is a retrospective study of 162 patients who underwent transurethral resection of prostate for benign prostatic hyperplasia between January 2007 and January 2008 at Prince Hussein Ben Abdullah Urology Center. The indications, surgical results and the occurrence of various complications were studied from the retrieved clinical records. Seventy-one patients [43.8%] underwent elective transurethral resection of prostate for significant lower urinary tract symptoms. Fifty patients [30.9%] had resection because of recurrent urine retention that had failed a trial without urinary catheter. The other patients had recurrent urinary tract infection [4.3%], recurrent hematuria of prostatic origin [6.8%], renal impairment [6.2%] or bladder stone [8.0%]. Seven patients [4.3%] developed urinary tract infection postoperatively. Secondary hemorrhage within four weeks postoperatively developed in three patients [1.8%]. Six patients developed urge incontinence. Urethral stricture occurred in two patients [1.2%] and one patient developed bladder neck contracture. One patient had bladder perforation. Only one patient [0.6%] suffered from transurethral resection syndrome in this study. Seven patients [4.3%] required blood transfusion during or after surgery. No episodes of immediate postoperative sepsis were encountered. There was no postoperative mortality. Transurethral resection of prostate is considered safe with low associated morbidity rate. Accordingly, transurethral resection of the prostate remains the 'gold standard' surgical treatment of benign prostatic hyperplasia and its complications